Clinical trials recruiting in Huangshi, China
9
Recruiting trials
12
Conditions
Phase breakdown
Phase 3 6Phase 4 1Not applicable 2
Conditions recruiting in Huangshi, China
Recruiting trials in Huangshi, China
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
- ASPIrin in Reducing Events in Dialysis ( ASPIRED )
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
- The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
Common questions
How many clinical trials are recruiting in Huangshi, China?
9 recruiting trials have at least one study site in Huangshi, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.